Test Price
4,500 AED✅ Home Collection Available
SELEX Sequencing and Analysis in UAE | 4500 AED | Precision Molecular Diagnostics
Executive Summary & Core Metrics
This high-precision molecular service uses Systematic Evolution of Ligands by Exponential Enrichment (SELEX) coupled with next-generation sequencing (NGS) to identify and characterise high-affinity DNA or RNA aptamers for diagnostic and therapeutic applications in oncology, rheumatology, and advanced biomedical research.
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation.
- ✓Insurance: Direct Billing Verification & Pre-Approval via WhatsApp +971 54 548 8731.
Test Overview & Methodology
SELEX Sequencing and Analysis is a high-precision molecular method that identifies and characterises DNA or RNA aptamers through iterative rounds of systematic evolution of ligands by exponential enrichment coupled with next-generation sequencing. This UAE-located service delivers complete aptamer selection analytics with single-nucleotide resolution and up to 10⁶-fold enrichment, enabling precise companion diagnostics and personalised therapeutic monitoring.
The methodology employs Illumina™-based high-throughput sequencing combined with advanced bioinformatic deconvolution to yield a comprehensive aptamer profile. Results are reported with full sequence annotation, target affinity metrics, and clinical interpretation guidance.
| Feature | Our Test – SELEX Sequencing (NGS-HTS) | Closest Alternative – Traditional SELEX (Gel-Based) |
|---|---|---|
| Precision | Single-nucleotide resolution, 10⁶-fold enrichment | Moderate resolution, manual clone-picking |
| Methodology | Illumina™-based HTS + bioinformatic deconvolution | Sanger sequencing of individual colonies |
| Turnaround Speed | 8 weeks (end-to-end including validation) | 12–16 weeks (labour-intensive) |
Physician Insight & Safety Protocols
“Aptamer-based diagnostics represent a transformative frontier in precision medicine; however, SELEX sequencing results must always be correlated with the patient’s full clinical picture. A negative or positive finding in isolation does not substitute for a comprehensive medical evaluation. I strongly advise discussing any results with your supervising specialist to ensure appropriate integration into your care plan. This test provides high-resolution molecular data that should be interpreted within the broader context of clinical history, physical examination, and other laboratory findings.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory on Medication & Clinical Management
Medication Advisory
Do not discontinue or alter any prescribed medication without consulting your treating physician. SELEX testing is intended for diagnostic refinement and research purposes; results alone do not warrant changes to established therapy. Always integrate molecular findings with a full clinical evaluation supervised by your primary care specialist.
Exclusion Criteria & Emergency Red Flags
Patient Exclusion Criteria
- Active febrile illness or systemic infection at the time of sample collection.
- Known severe coagulopathy contraindicating venipuncture.
- Inability to provide informed consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency: If you experience sudden onset of severe pain, dyspnoea, or anaphylaxis after sample collection, seek immediate care at the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the exact clinical purpose of SELEX sequencing and how does it benefit me?
SELEX sequencing identifies high-affinity oligonucleotide aptamers that bind disease-specific targets with extreme specificity, enabling precise companion diagnostics and personalised therapeutic monitoring. The test provides a comprehensive molecular profile that aids in selecting targeted therapies and tracking treatment response in oncology, rheumatology, and other chronic conditions.
2. Do I need a doctor’s referral to order this test, and how is the sample collected?
A physician’s referral is strongly recommended to ensure appropriate clinical context and to facilitate insurance pre-approval. Our licensed phlebotomists collect whole blood or extracted DNA during a scheduled home visit within 8 AM–11 PM under ISO-certified cold-chain standards. The sample is transported under temperature-controlled conditions to our Dubai Healthcare City laboratory.
3. How reliable are my data and will my insurance cover this molecular test?
Your results are generated under ISO 9001:2015 certification with rigorous bioinformatic validation and quality control checks at each sequencing stage. Direct billing verification with UAE insurers is initiated via WhatsApp before processing begins. Coverage depends on your policy and the specific clinical indication; our insurance team will confirm pre-approval prior to sample collection.
UAE Regulatory & Data Privacy Adherence
This service strictly adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic sequence data, aptamer profiles, and personal health information are encrypted, access-controlled, and processed exclusively within accredited UAE facilities. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE maintains full compliance with DHA regulatory standards for molecular diagnostics and genetic testing.
Clinical & Logistical Metadata
| Test Name | SELEX Sequencing and Analysis (NGS-Based Aptamer Selection) |
| Price (AED) | 4,500 AED |
| Turnaround Time | 8 weeks (end-to-end including validation) |
| Sample Type / Matrix | Whole Blood (peripheral) or Extracted DNA |
| Methodology Used | Illumina™-based High-Throughput Sequencing (NGS) coupled with SELEX enrichment and bioinformatic deconvolution |
| ICD-10-CM Code | Z01.89 |
| LOINC Code | 93367-2 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians